Page 542 - Problem-Based Feline Medicine
P. 542

534   PART 8   CAT WITH ABNORMAL LABORATORY DATA


          Clinical signs                                Treatment

          Lethargy, anorexia, weakness, pale mucous membranes  Administer potassium phosphates at 0.03–0.12
          and elevated heart and respiratory rates occur.  mmol/kg/h until normophosphatemic.
          History of exposure to oxidative toxins like acetamin-  Alternately, prevent hypophosphatemia (and hypo-
          ophen (iatrogenic), onions (foodstuffs like babyfood),  kalemia) by giving calculated potassium require-
          zinc (United States pennies, airline carrier hardware),  ments as 30% potassium chloride and 50% potassium
          propothiouracil (iatrogenic), methylene blue (iatro-  dihydrophosphate.
          genic), phenazopyridine (iatrogenic), vitamin K1 (iatro-
                                                        Phosphate concentrations are usually maintained
          genic), propylene glycol (food stuffs; carrier in some
                                                        within normal concentrations by diet alone after reso-
          medications), and benzocaine derivatives (iatrogenic).
                                                        lution of the ketoacidotic crisis.

          Diagnosis                                     MICROANGIOPATHIC HEMOLYTIC ANEMIA*
          Heinz bodies (intracytoplasmic irregular retractile
                                                         Classical signs
          granules) are seen cytologically on thin blood smears.
                                                         ● Lethargy, anorexia, depression.
          Methemoglobin levels can be elevated; blood has a
                                                         ● Clinical signs of the primary disease.
          brown color.

          Treatment                                     Clinical signs
          Remove the source of the oxidant injury.      Diseases that involve small vessels like disseminated
                                                        intravascular coagulation (fibrin strands), dirofilari-
          N-acetylcysteine at 140 mg/kg, PO, once followed by
                                                        asis, and splenic tumors or hematomas damage RBC
          70 mg/kg, PO every 4–6 hours if severe methemoglo-
                                                        resulting in formation of schistocytes or fragments.
          binemia is present.
                                                        History, physical examination, and laboratory assess-
          Supportive care including whole blood transfusion if
                                                        ment support the primary disease.
          needed.
                                                        Lethargy, depression, weakness and pale mucous mem-
                                                        branes may result if anemia is severe.
          HYPOPHOSPHATEMIA*
           Classical signs                              Diagnosis
           ● Anemia, muscle weakness in diabetic cat.   Schistocytes are seen cytologically on thin blood
           ● Ataxia, seizures.                          smears.
                                                        Diagnostic work-up for the suspected primary cause
          Clinical signs                                should be performed.

          Extreme hypophosphatemia may occur during initial
          treatment of ketoacidotic diabetes mellitus, and  CYTAUXZOONOSIS
          result in muscle weakness, ataxia, seizures and  pale
          mucous membranes.                              Classical signs
          Liver disease may result in red blood cell fragility.  ● Fever, depression, shock and death.
                                                         ● Indoor/outdoor cats in the Gulf Coast
          Diagnosis                                        states.
                                                         ● History of tick exposure.
          Measurement of serum phosphorus concentrations.
   537   538   539   540   541   542   543   544   545   546   547